95 related articles for article (PubMed ID: 22349379)
1. [Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray].
Peng X; Tan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):48-52. PubMed ID: 22349379
[TBL] [Abstract][Full Text] [Related]
2. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
3. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
[TBL] [Abstract][Full Text] [Related]
4. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
5. [Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells].
Li W; Tan GL; Ma YH; Peng XW; He GX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 45(12):1035-40. PubMed ID: 21215055
[TBL] [Abstract][Full Text] [Related]
6. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.
Song Y; Peng X; Wang M; Xie J; Tan G
Int J Clin Exp Pathol; 2015; 8(9):11314-22. PubMed ID: 26617855
[TBL] [Abstract][Full Text] [Related]
8. Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.
Zhang X; Li W; Li H; Ma Y; He G; Tan G
Anticancer Drugs; 2012 Sep; 23(8):856-64. PubMed ID: 22824824
[TBL] [Abstract][Full Text] [Related]
9. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of α folate receptor resulting in a reversal of taxol resistance in nasopharyngeal carcinoma.
Li W; Tan G; Ma Y; Li H; He G
Otolaryngol Head Neck Surg; 2012 Feb; 146(2):250-8. PubMed ID: 22041223
[TBL] [Abstract][Full Text] [Related]
11. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].
Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
13. Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.
Sun Y; Chen X; Zhou Y; Qiu S; Wu Y; Xie M; Zhu G; Liang S; Li H; Zhou D; Ju Z; Wang F; Han F; Wang Z; Wang R
Int J Med Sci; 2020; 17(16):2416-2426. PubMed ID: 33029084
[No Abstract] [Full Text] [Related]
14. MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines.
Duan Z; Brakora KA; Seiden MV
Gene; 2004 Sep; 340(1):53-9. PubMed ID: 15556294
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.
Wang X; Ling MT; Guan XY; Tsao SW; Cheung HW; Lee DT; Wong YC
Oncogene; 2004 Jan; 23(2):474-82. PubMed ID: 14724576
[TBL] [Abstract][Full Text] [Related]
17. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells.
Zhang X; Wang Q; Ling MT; Wong YC; Leung SC; Wang X
Int J Cancer; 2007 May; 120(9):1891-8. PubMed ID: 17230521
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
Zuo Q; Luo RC
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic interactions of TRAIL and paclitaxel on the nasopharyngeal carcinoma cell lines in vitro].
Tan P; Liu Y; Qiu Y; Li S; Guo Y; Li G; Tian Y; Zhang X; Huang D; Xiao J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(7):319-22. PubMed ID: 22737875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
